TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation.

Ashley Woods et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.